Sanofi

Sanofi P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Sanofi (SAN.PA) as of Nov 4, 2026 is 10.46. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 15.97 — a change of -34.51% (lower).

P/FCF

10.46

YoY

-34.51%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Sanofi is 2025 10.46 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Sanofi was 2024 15.97 . It decreases by -34.51% lower compared to the previous year.

The Sanofi P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
26.34 EUR
Jan 1, 2019
15.86 EUR
Jan 1, 2020
17.62 EUR
Jan 1, 2021
11.09 EUR
Jan 1, 2022
11.29 EUR
Jan 1, 2023
10.88 EUR
Jan 1, 2024
15.97 EUR
Jan 1, 2025
10.46 EUR
The Sanofi P/FCF history
YEARP/FCFYoY
10.46-34.51%
15.97+46.77%
10.88-3.63%
11.29+1.85%
11.09-37.08%
17.62+11.12%
15.86-39.78%
26.34+51.90%
17.34+6.12%
16.34+6.83%
15.29-0.24%
15.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Sanofi is 10.46 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Sanofi changed from 15.97 to 10.46, representing a -34.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Sanofi since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Sanofi with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Sanofi

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Sanofi